This content is intended for educational purposes only. Please note that the availability of the products mentioned may vary by country, and it is recommended to check with your local stock exchange.

Please note that VanEck may offer investment products that invest in the asset class(es) or industries included in herein.

This is not an offer to buy or sell, or a recommendation to buy or sell any of the securities, financial instruments or digital assets mentioned herein. The information presented does not involve the rendering of personalized investment, financial, legal, tax advice, or any call to action. Certain statements contained herein may constitute projections, forecasts and other forward-looking statements, which do not reflect actual results, are for illustrative purposes only, are valid as of the date of this communication, and are subject to change without notice. Actual future performance of any assets or industries mentioned are unknown. Information provided by third party sources are believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. VanEck does not guarantee the accuracy of third party data. The information herein represents the opinion of the author(s), but not necessarily those of VanEck or its other employees.

An investment in the Fund may be subject to risks which include, but are not limited to, risks related to the Fund’s principal investment strategies, health care sector, industrials sector, information technology sector, financials sector, special risk considerations of investing in China and Chinese-issued A-shares, ChiNext Market, Stock Connect, PRC tax, foreign securities, emerging market issuers, foreign currency, medium-capitalization companies, cash transactions, equity securities, market, operational, index tracking, authorized participant concentration, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium/discount, liquidity of fund shares, non-diversification, index-related concentration and high portfolio turnover risks, all of which may adversely affect the Fund. Emerging market issuers and foreign securities may be subject to securities markets, political and economic, investment and repatriation restrictions, different rules and regulations, less publicly available financial information, foreign currency and exchange rates, operational and settlement, and corporate and securities laws risks. Medium-capitalization companies may be subject to elevated risks. Investments in China may also be subject to risks which include political and economic, inflation, tax changes, nationalization and expropriation, Hong Kong policy, Chinese securities markets, less stringent disclosure, regulatory standards, and publicly available information on Chinese issuers, and Chinese corporate and securities law risks Investments in Chinese-issued A-shares may also be subject to risks related to investment and repatriation restrictions, loss of favorable U.S. tax treatment, tax on retained income and gains, foreign exchange control, custody risks, foreign currency considerations, and China-related index tracking risks.

Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of the Fund carefully before investing. To obtain a prospectus and summary prospectus, which contains this and other information, call 800.826.2333 or visit vaneck.com. Please read the prospectus and summary prospectus carefully before investing.

© Van Eck Securities Corporation, Distributor